First Quarter Revenues of $280.1 Million, up 28.5% on a Reported Basis and up 28.1% on a Constant Currency Basis; Adjusted EBITDA up 20.7% on a Reported Basis and up 20.7% on a Constant Currency Basis; Company Updates Guidance, Announces Quarterly Dividend and Provides Supplemental Information
WESTLAKE, Texas , Nov.
Family Dollar Stores, Inc. (NYSE: FDO) today reported that net income
per diluted share in the first quarter of fiscal 2015 ended November 29,
2014, was $0.36 compared to $0.68 in the first quarter of fiscal 2014
ended November 30, 2013.
Meridian Bioscience, Inc. (NASDAQ: VIVO):
Meridian Bioscience, Inc. (NASDAQ: VIVO) today:
Reported record first quarter net revenues of $48.0 million, an
increase of 7% from the same period of the prior fiscal year;
reported first quarter operating income of $12.7 million, an increase
of 9% from the same period of the prior fiscal year;
reported first quarter net earnings of $7.9 million, or $0.19 per
diluted share, an increase of 6% compared to the fiscal 2014 first
declared the regular quarterly cash dividend of $0.20 per share for
the first quarter of fiscal 2015 (annual indicated rate of $0.80 per
share), the same as the regular quarterly rate for fiscal 2014; and
reaffirmed its fiscal 2015
First Quarter Results (compared to last year's first quarter) - Total revenue decreased 17% to $451 million - Social gaming revenue increased 23% to $79 million and average DAU grew 11% to 1.9 million
- Adjusted earnings per share decreased 24% to $0.19 - GAAP earnings per share decreased 55% to $0.14 - Returned $55 million to shareholders in the form of dividends LAS VEGAS , Jan.
Digi International ® Inc. (NASDAQ: DGII) reported revenue of
$48.7 million for the first fiscal quarter of 2015, compared with $47.3
million for the first fiscal quarter of 2014, an increase of $1.4
million, or 3.0%. Net loss for the first fiscal quarter of 2015 was $0.3
million, or $0.01 loss per diluted share, compared to net income of $0.7
million, or $0.03 per diluted share, in the prior year comparable
Sevion Therapeutics, Inc. ("Sevion" or the "Company") (OTCQB:SVON), a
biopharmaceutical company which discovers, develops and acquires
next-generation biologics for the treatment of cancer and immunological
diseases, today reported financial results for the fiscal quarter ended
September 30, 2014 (“First Quarter 2015”).
"During the first fiscal quarter of 2015, we made a strategic decision
to focus our efforts and resources on our proprietary antibody discovery
technology platforms, including two promising antibodies that are
advancing toward IND status,” said Ronald Martell, Chief Executive
Officer of Sevion.
AmerisourceBergen Corporation (NYSE:ABC) today reported that in its
fiscal year 2015 first quarter ended December 31, 2014, adjusted diluted
earnings per share from continuing operations increased 42.5 percent to
$1.14. Revenue increased 15.1 percent to $33.6 billion in the quarter.
Sales reach US$56.7 million , up year-over-year from US$56.0 million Gross margin amounts to 62.6% of sales, up year-over-year from 62.2% Adjusted EBITDA totals US$3.2 million , up year-over-year from US$2.3 million QUEBEC CITY, Jan.
Sign-up for Commercial Metals Company Reports First Quarter Earnings Per Share Of $0.30, Earnings Per Share From Continuing Operations Of $0.32, And Announces Quarterly Dividend Of $0.12 Per Share investment picks
Premium Membership: Features and Benefits
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.